Company Info
Phone(617) 923-1400
Year Established
2008
Contacts
Carston Brunn, Ph.D.President & CEO
Lloyd Johnston, Ph.D.
COO
Takashi Kei Kishimoto, Ph.D.
CSO
Peter G. Traber
CMO
Blaine Davis
CFO
Company Description
Selecta Biosciences is leveraging its clinically-validated ImmTORTM platform to develop antigen-specific tolerogenic therapies.
